Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients

Coronavirus disease 2019 (COVID-19), a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic in March 2020, and has caused more than 600,000 deaths in the United States at the time of this report. Hematopoietic stem cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mushtaq, Muhammad Umair, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Luder, Mary, Ahmed, Nausheen, Abdelhakim, Haitham, Bansal, Rajat, Balusu, Ramesh, DeJarnette, Shaun, Divine, Clint, Kribs, Robert, Shune, Leyla, Singh, Anurag K., Ganguly, Siddhartha, Abhyankar, Sunil H., McGuirk, Joseph P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272625/
https://www.ncbi.nlm.nih.gov/pubmed/34256172
http://dx.doi.org/10.1016/j.jtct.2021.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272625/
https://www.ncbi.nlm.nih.gov/pubmed/34256172
http://dx.doi.org/10.1016/j.jtct.2021.07.005

Ejemplares similares